Latest cyclophosphamide Stories
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
BRIDGEWATER, N.J., Dec.
CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
Today, individuals with lupus nephritis benefit from better treatments than a decade ago.
Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels.
Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy.
MISSISSAUGA, ON, Nov. 18 /PRNewswire-FirstCall/ - YM BioSciences Inc.
Finland, November 11 /PRNewswire/ -- - This is a third party press release.
Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy.
WALTHAM, Mass., Aug.
- Emitting flashes of light; glittering.